Xarelto Defendants: Third Time Lucky
Xarelto Defendants: Third Time Lucky
Introduction
The third straight win for Xarelto defendants in the Xarelto MDL No. 2592 bellwether trial, boosts the defendant's stand regarding the safety and efficacy of Xarelto. Bayer released a statement saying, ''that its FDA-approved label contains accurate, science-based information on the benefits and risks of this life-saving medicine.” This decision came in by the Mississippi federal jury in favor of the defendants: J&J's Janssen Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc. The plaintiff alleged that the Prothrombin Time (PT) test which is used to assess a patient's risks for bleeding, was not informed and instructed to the doctors by the manufacturers. This was opposed by the defendant's say that the PT test was not scientifically reliable.
Comments
Latest News
Pesticide Shield Bill Faces Long Odds in Missouri Senate
Categories: General
Legislation aimed at making it harder to sue pesticide manufacturers over cancer claims is facing a critical deadline, with an unusual coalition of opponents striving to stall its progress.
…Philips Sues CPAP Cleaner SoClean to Share Settlement Costs
Categories: Settlements
Philips has filed a lawsuit against SoClean, a company that manufactures ozone-based cleaning systems…
NJ Pharma Settles: Cash, Narcan for Delaware
Categories: Settlements
Amneal Pharmaceuticals, a New Jersey-based drug manufacturer, has reached a settlement agreement with Delaware and other states over its involvement in the…